NCT06047379 2026-03-02Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisNeonc Technologies, Inc.Phase 1/2 Recruiting134 enrolled
NCT00003597 2014-07-24Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid TumorsChildren's Oncology GroupPhase 1 Completed16 enrolled